보험금
1. The Defendant’s KRW 31,00,000 as well as 20% per annum from June 17, 2015 to September 30, 2015 to the Plaintiff.
1. The insured worker's insurance premium amount for the beneficiary on the date of the contract under the name of the basic fact-finding contract, non-dividend 21C Cancer Treatment Insurance Contract on November 25, 1994, B 63,000 won upon the expiration of the second maturity of the insured worker on November 25, 1994, the plaintiff's disability of hospitalization and other plaintiff;
A. On November 25, 1994, B entered into an insurance contract with the Defendant as described in the following table (hereinafter “instant insurance”). On February 25, 2013, B received the cruptary administration from the Seoul Asan Hospital on February 6, 2013 after receiving the cruptic administration.
Article 10 (Grounds for Payment of Insurance Money) (1) A company shall pay the insurance money or benefits (referring to the Schedule of Standard for Payment of Insurance Money in attached Table 1) to the beneficiary when any of the following events occurs to the main insured or the subordinate insured provided for in Article 2 (Scope of Insured) during the insurance period:
1. Where the first cancer is diagnosed after the commencing date of liability provided for in Article 6 (Effect of Contracts) and the first cancer is confirmed: Payment of cancer treatment insurance proceeds;
2. When the principal insured or the insured has confirmed the first diagnosis of cancer after the date of commencing the responsibility provided for in Article 6 (Effect of Contracts) and continued to be hospitalized for at least four days for the direct purpose of treating such cancer (if the company recognizes it even if he/she moved into a hospital, he/she shall be deemed hospitalized and if it is recognized by the company, hereinafter the same shall apply): The payment of cancer hospitalization benefits;
3. The definitions and places of hospitalization under Article 11 below omitted. The term "inpatient" in this contract means admission to a hospital or clinic (excluding herb clinic) as provided for in Article 3 (2) of the Medical Service Act because it is difficult to treat at home, etc. and it is deemed necessary to treat cancer or liver disease by a doctor, dentist, or a person qualified as an oriental medical doctor (hereinafter referred to as "doctor") of a hospital in the Republic of Korea.
(Attachment I).